Ranking the role of RANK ligand in apoptosis

被引:41
作者
Bharti, AC
Aggarwal, BB
机构
[1] Univ Texas, MD Anderson Canc Ctr, Cytokine Res Sect, Dept Expt Therapeut, Houston, TX 77030 USA
[2] ICMR, Inst Cytol & Prevent Oncol, Noida, Uttar Pradesh, India
关键词
Akt; apoptosis; cell cycle arrest; JNK; NF-kappa B; PI3Kinase; RANK; RANKL; TRAF6;
D O I
10.1023/B:APPT.0000045780.10463.c6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many members of tumor necrosis factor (TNF) superfamily are characterized by their ability to induce apoptosis once they bind in a homotrimeric manner to their cognate receptors. The receptor activator of nuclear factor-kappaB ligand (RANKL), a member of the TNF superfamily identified seven years ago, was originally described as a factor that induced osteoclastogenesis and dendritic cell survival. Recent observations indicate that a growth inhibitory and apoptosis-inducing activity is associated with RANKL, as is the case for other members of TNF superfamily. This review describes the possible mechanisms of induction of RANKL-induced growth inhibition/apoptosis and discusses the role of various components in RANKL-signaling in this phenomenon, including TNF receptor-associated factor (TRAF)-6, nuclear factor-kappaB (NF-kappaB), c-jun N-terminal kinase JNK), phosphatidylinositol-3 kinase (PI3K).
引用
收藏
页码:677 / 690
页数:14
相关论文
共 150 条
  • [1] Abu-Amer Y, 2000, J BIOL CHEM, V275, P27307
  • [2] Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor
    AbuAmer, Y
    Ross, FP
    Edwards, J
    Teitelbaum, SL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) : 1557 - 1565
  • [3] Aggarwal Bharat B., 2002, Current Drug Targets - Inflammation and Allergy, V1, P327, DOI 10.2174/1568010023344571
  • [4] A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
    Anderson, DM
    Maraskovsky, E
    Billingsley, WL
    Dougall, WC
    Tometsko, ME
    Roux, ER
    Teepe, MC
    DuBose, RF
    Cosman, D
    Galibert, L
    [J]. NATURE, 1997, 390 (6656) : 175 - 179
  • [5] Targeting death and decoy receptors of the tumour-necrosis factor superfamily
    Ashkenazi, A
    [J]. NATURE REVIEWS CANCER, 2002, 2 (06) : 420 - 430
  • [6] Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts
    Azuma, Y
    Kaji, K
    Katogi, R
    Takeshita, S
    Kudo, A
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) : 4858 - 4864
  • [7] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [8] Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells)
    Bao, HF
    Jacobs-Helber, SM
    Lawson, AE
    Penta, K
    Wickrema, A
    Sawyer, ST
    [J]. BLOOD, 1999, 93 (11) : 3757 - 3773
  • [9] C-myc is required for osteoclast differentiation
    Battaglino, R
    Kim, D
    Fu, J
    Vaage, B
    Fu, XY
    Stashenko, P
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (05) : 763 - 773
  • [10] Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
    Baud, V
    Liu, ZG
    Bennett, B
    Suzuki, N
    Xia, Y
    Karin, M
    [J]. GENES & DEVELOPMENT, 1999, 13 (10) : 1297 - 1308